My Quote Request
No products added yet
6505-01-199-8358
20 Products
NDC50419-0192-50
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505011998358
NSN
6505-01-199-8358
NDC50419-0192-50
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505011998358
NSN
6505-01-199-8358
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVASCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
ANGIOVIST 282
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505011998358
NSN
6505-01-199-8358
ANGIOVIST 282
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505011998358
NSN
6505-01-199-8358
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVASCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
7896242441259
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
7896242441259
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
MFG
BARENBOIM CIA LTDA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: D DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
95-0317
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
95-0317
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: D DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00517-2610-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
NDC00517-2610-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505011998359
NSN
6505-01-199-8359
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: D DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00093-0149-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
NDC00093-0149-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN TABLETS USP 500 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0451-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
NDC00378-0451-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN TABLETS USP 500 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC53746-0190-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
NDC53746-0190-01
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
MFG
AMNEAL PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN TABLETS USP 500 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC67253-0622-10
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
NDC67253-0622-10
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012002474
NSN
6505-01-200-2474
MFG
DAVA PHARMACEUTICALS INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN TABLETS USP 500 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00469-4400-30
SELENIUM INJECTION
NSN, MFG P/N
6505012005777
NSN
6505-01-200-5777
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MICROGRAMS SELENIUM PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELENIUM INJECTION 40MCG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LYPHOMED INC
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-8820-30
SELENIUM INJECTION
NSN, MFG P/N
6505012005777
NSN
6505-01-200-5777
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MICROGRAMS SELENIUM PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELENIUM INJECTION 40MCG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LYPHOMED INC
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
SELEPEN
SELENIUM INJECTION
NSN, MFG P/N
6505012005777
NSN
6505-01-200-5777
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MICROGRAMS SELENIUM PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELENIUM INJECTION 40MCG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LYPHOMED INC
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00173-0352-30
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012005784
NSN
6505-01-200-5784
NDC00173-0352-30
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012005784
NSN
6505-01-200-5784
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ZINACEF
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012005784
NSN
6505-01-200-5784
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00005-5360-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
NDC00005-5360-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 19.60 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.14 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE SUCCINATE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2711-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
NDC00781-2711-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
MFG
GENEVA PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 19.60 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.14 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE SUCCINATE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC17236-0694-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
NDC17236-0694-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
MFG
DIXON-SHANE LLC DBA R & S NORTHEAST
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 19.60 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.14 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE SUCCINATE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52544-0812-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
NDC52544-0812-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505012005786
NSN
6505-01-200-5786
MFG
WATSON LABS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 19.60 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.14 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE SUCCINATE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ACETAMINOPHEN UNISERTS
ACETAMINOPHEN SUPPOSITORIES,USP
NSN, MFG P/N
6505012005790
NSN
6505-01-200-5790
ACETAMINOPHEN UNISERTS
ACETAMINOPHEN SUPPOSITORIES,USP
NSN, MFG P/N
6505012005790
NSN
6505-01-200-5790
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 120.000 ACETAMINOPHEN MILLIGRAMS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN SUPPOSITORIES 120 125MG CHILD RECTAL I.S. 12S
PRIMARY CONTAINER TYPE: PACKAGE
SUPPOSITORY TYPE: CHILD RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC00182-1662-11
ACETAMINOPHEN SUPPOSITORIES,USP
NSN, MFG P/N
6505012005790
NSN
6505-01-200-5790
NDC00182-1662-11
ACETAMINOPHEN SUPPOSITORIES,USP
NSN, MFG P/N
6505012005790
NSN
6505-01-200-5790
MFG
IVAX CORP
Description
ACTIVE INGREDIENT AND STRENGTH: 120.000 ACETAMINOPHEN MILLIGRAMS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN SUPPOSITORIES 120 125MG CHILD RECTAL I.S. 12S
PRIMARY CONTAINER TYPE: PACKAGE
SUPPOSITORY TYPE: CHILD RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
